On this page

Buminate, Flexbumin

Albumin (Human)

351(a) Standalone BLA

Overview

Source: Purple Book
Proprietary name
Buminate, Flexbumin
Proper name
Albumin (Human)
Licence type
351(a)
BLA number
101452
Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Center
CBER
Presentations
5
First licensure
—

Presentations

Source: Purple Book
Every strength and presentation recorded in the Purple Book for this product.
Strength Dosage form Route Presentation Status Licensed
10G/50ML Injection Intravenous Bottle Rx March 3, 1954
12.5G/250ML Injection Intravenous Bottle Rx March 3, 1954
12.5G/50ML Injection Intravenous Bottle Rx March 3, 1954
20G/100ML Injection Intravenous Bottle Rx March 3, 1954
25G/100ML Injection Intravenous Bottle Rx March 3, 1954

Sources for this page

Purple Book FDA Licence type, presentations, reference product, exclusivity